Drugs / GAA/TT-peptide vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT00795457 | Jan 2009 → Feb 2013 | low-grade astrocytoma, oligoastrocytoma | Ian F. Pollack, M.D. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GAA/TT-peptide vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00795457 ↗ |
| Modality | Vaccine | “This is a pilot vaccine study in adults with either WHO grade II astrocytoma, oligoastrocytoma or oligodendroglioma.” NCT00795457 ↗ |
| Route | Subcutaneous | “subcutaneous injections of GAA/TT-vaccines” NCT00795457 ↗ |